» Articles » PMID: 24902583

Salmonella Typhi and Salmonella Paratyphi A Elaborate Distinct Systemic Metabolite Signatures During Enteric Fever

Overview
Journal Elife
Specialty Biology
Date 2014 Jun 7
PMID 24902583
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The host-pathogen interactions induced by Salmonella Typhi and Salmonella Paratyphi A during enteric fever are poorly understood. This knowledge gap, and the human restricted nature of these bacteria, limit our understanding of the disease and impede the development of new diagnostic approaches. To investigate metabolite signals associated with enteric fever we performed two dimensional gas chromatography with time-of-flight mass spectrometry (GCxGC/TOFMS) on plasma from patients with S. Typhi and S. Paratyphi A infections and asymptomatic controls, identifying 695 individual metabolite peaks. Applying supervised pattern recognition, we found highly significant and reproducible metabolite profiles separating S. Typhi cases, S. Paratyphi A cases, and controls, calculating that a combination of six metabolites could accurately define the etiological agent. For the first time we show that reproducible and serovar specific systemic biomarkers can be detected during enteric fever. Our work defines several biologically plausible metabolites that can be used to detect enteric fever, and unlocks the potential of this method in diagnosing other systemic bacterial infections.

Citing Articles

Study of Bacterial Communities in Water and Different Developmental Stages of from Aquatic Breeding Sites in Leticia City, Colombian Amazon Biome.

Castaneda-Espinosa A, Duque-Granda D, Cadavid-Restrepo G, Murcia L, Junca H, Moreno-Herrera C Insects. 2025; 16(2).

PMID: 40003826 PMC: 11856942. DOI: 10.3390/insects16020195.


Evolving Epidemiology and Antibiotic Resistance in Enteric Fever: A Comprehensive Review.

Hamdulay K, Rawekar R, Tayade A, Kumar S, Acharya S Cureus. 2024; 16(6):e63070.

PMID: 39055401 PMC: 11272152. DOI: 10.7759/cureus.63070.


Enteric Fever: Diagnostic Challenges and the Importance of Early Intervention.

Saha T, Arisoyin A, Bollu B, Ashok T, Babu A, Issani A Cureus. 2023; 15(7):e41831.

PMID: 37575696 PMC: 10423039. DOI: 10.7759/cureus.41831.


From to Typhi: The Fascinating Journey of the Virulence and Pathogenicity of Typhi.

Chatterjee R, Roy Chowdhury A, Mukherjee D, Chakravortty D ACS Omega. 2023; 8(29):25674-25697.

PMID: 37521659 PMC: 10373206. DOI: 10.1021/acsomega.3c02386.


Diagnostics for Typhoid Fever: Current Perspectives and Future Outlooks for Product Development and Access.

Sapkota J, Roberts T, Basnyat B, Baker S, Hampton L, Dittrich S Open Forum Infect Dis. 2023; 10(Suppl 1):S17-S20.

PMID: 37274534 PMC: 10236505. DOI: 10.1093/ofid/ofad120.


References
1.
Vollaard A, Ali S, van Asten H, Widjaja S, Visser L, Surjadi C . Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA. 2004; 291(21):2607-15. DOI: 10.1001/jama.291.21.2607. View

2.
Koirala K, Thanh D, Thapa S, Arjyal A, Karkey A, Dongol S . Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever. Antimicrob Agents Chemother. 2012; 56(5):2761-2. PMC: 3346606. DOI: 10.1128/AAC.06414-11. View

3.
Glynn J, Hornick R, Levine M, Bradley D . Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used. Epidemiol Infect. 1995; 115(1):23-30. PMC: 2271553. DOI: 10.1017/s0950268800058088. View

4.
Holmes E, Antti H . Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst. 2003; 127(12):1549-57. DOI: 10.1039/b208254n. View

5.
Langley R, Tsalik E, van Velkinburgh J, Glickman S, Rice B, Wang C . An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013; 5(195):195ra95. PMC: 3924586. DOI: 10.1126/scitranslmed.3005893. View